Quick Takeaways
- Erin Lavelle has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Erin Lavelle
- Location
- Bothell, WA
- Signature
- /s/ Douglas Carlson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Erin Lavelle and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Aerovate Therapeutics, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Erin Lavelle
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JBIO | Aerovate Therapeutics, Inc. | Director | 29 Apr 2025 | |||
| AVLN | Avalyn Pharma Inc. | Director | 29 Apr 2026 | |||
| CLYM | Eliem Therapeutics, Inc. | Coo & Cfo | 31 Oct 2022 | |||
| NGNE | Neoleukin Therapeutics, Inc. | Director | 08 Jun 2023 |
Insider Transactions Reported by Erin Lavelle:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.